Clinical Trial Detail

NCT ID NCT03101839
Title Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

AZD4785

Age Groups: senior adult

No variant requirements are available.